Skip to content

A Single-arm Single-center Prospective Study of the Treatment of Stanford Type B Aortic Dissection with an Unhealthy or Short Anchorage Zone Using the Technique of During-operation Fenestrated Thoracic Endovascular Repair (TEVAR)

A Single-arm Single-center Prospective Study of the Treatment of Stanford Type B Aortic Dissection with an Unhealthy or Short Anchorage Zone Using the Technique of During-operation Fenestrated Thoracic Endovascular Repair (TEVAR)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16008792
Enrollment
Unknown
Registered
2016-07-06
Start date
2016-07-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic dissection

Interventions

A:During-operation Fenestrated Thoracic Endovascular Repair (TEVAR)

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years old; 2. Clinically diagnosed of having a Stanford type B aortic dissection; 3. Imaging shows that the length of the proximal anchorage zone is over or equal to 15mm,yet the anchorage zone is on reversely-teared dissection or hematoma;or image shows that the lenth of the proximal anchorage zone is less than 15mm. The proximal vascular diameter is between 19mm and 41mm; 4. Agree to have an operation and follow-up visits that the trial requires, and voluntarily sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Vascular anomalies involving the location of endovascular intervention; 2. Clinically considered of connective tissue related vascular diseases; 3. Suffer from organic diseases of heart, brain, lung etc. that is considered not suitable for treatment; 4. Hematological diseases or hemorrhage; 5. Cerebral diseases,abnormal judgment ability; 6. Obvious function abnormalities of liver or kidney(blood ALT=80U/L,blood Cr=178umol/L); 7. Females during gestation or lactation period; 8. The target lesion involves major organic vessels or is severely twisted, angled, or calcificated; 9. Malignant neoplasms or other severe diseases; 10. Allergic to contrast media.

Design outcomes

Primary

MeasureTime frame
The thrombosis rate of false lumen in the stent section 12 months after surgery;

Countries

China

Contacts

Public ContactXiangchen Dai

Tianjin Medical University General Hospital

13302165917@163.com+86 13302165917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026